AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
C: Locoregional targeting immunochemotherapy for resectable and unresectable pancreatic head carcinoma: The Athens experience
Authors: Lygidakis, NJ Vlachos, L Raptis, S Rassidakis, G Kittas, C
Citation: Nj. Lygidakis et al., C: Locoregional targeting immunochemotherapy for resectable and unresectable pancreatic head carcinoma: The Athens experience, MD AND SOIL, 2002, pp. 280-285
Acute biliary pancreatitis: Staging and management
Authors: Schietroma, M Carlei, F Lezoche, E Rossi, M Liakos, CH Mattucci, S Lygidakis, NJ
Citation: M. Schietroma et al., Acute biliary pancreatitis: Staging and management, HEP-GASTRO, 48(40), 2001, pp. 988-993
Tumor immunity and immunotherapy
Authors: Boura, P Kountouras, J Lygidakis, NJ
Citation: P. Boura et al., Tumor immunity and immunotherapy, HEP-GASTRO, 48(40), 2001, pp. 1040-1044
Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study
Authors: Lygidakis, NJ Sgourakis, G Dedemadi, G Safioleus, MC Nestoridis, J
Citation: Nj. Lygidakis et al., Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study, HEP-GASTRO, 48(40), 2001, pp. 1085-1087
Building on excellence
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Building on excellence, HEP-GASTRO, 48(39), 2001, pp. NIL_17-NIL_17
Evaluation of immune response in patients after open or laparoscopic cholecystectomy
Authors: Schietroma, M Carlei, F Lezoche, E Agnifili, A Enang, GN Mattucci, S Minervini, S Lygidakis, NJ
Citation: M. Schietroma et al., Evaluation of immune response in patients after open or laparoscopic cholecystectomy, HEP-GASTRO, 48(39), 2001, pp. 642-646
Liver regeneration after hepatectomy
Authors: Kountouras, J Boura, P Lygidakis, NJ
Citation: J. Kountouras et al., Liver regeneration after hepatectomy, HEP-GASTRO, 48(38), 2001, pp. 556-562
Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience
Authors: Lygidakis, NJ Sgourakis, GJ Dedemadi, GV Vlachos, L Safioleas, M
Citation: Nj. Lygidakis et al., Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience, HEP-GASTRO, 48(37), 2001, pp. 95-101
Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma
Authors: Lygidakis, NJ Sgourakis, G Dedemadi, G Spentzouris, N Kontis, A Nestoridis, J
Citation: Nj. Lygidakis et al., Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma, HEP-GASTRO, 47(36), 2000, pp. 1546-1554
Moving forward with our guiding philosophy
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Moving forward with our guiding philosophy, HEP-GASTRO, 47(35), 2000, pp. NIL_23-NIL_23
New concepts of molecular biology for colon carcinogenesis
Authors: Kountouras, J Boura, P Lygidakis, NJ
Citation: J. Kountouras et al., New concepts of molecular biology for colon carcinogenesis, HEP-GASTRO, 47(35), 2000, pp. 1291-1297
Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease
Authors: Kountouras, J Boura, P Lygidakis, NJ
Citation: J. Kountouras et al., Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease, HEP-GASTRO, 47(35), 2000, pp. 1301-1304
Pancreatic cancer: Current factors and options to determine future research
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Pancreatic cancer: Current factors and options to determine future research, HEP-GASTRO, 47(34), 2000, pp. 1170-1175
New epidemiological data on liver oncogenesis
Authors: Kountouras, J Lygidakis, NJ
Citation: J. Kountouras et Nj. Lygidakis, New epidemiological data on liver oncogenesis, HEP-GASTRO, 47(33), 2000, pp. 855-861
Untitled
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Untitled, HEP-GASTRO, 47(32), 2000, pp. NIL_21-NIL_22
Untitled
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Untitled, HEP-GASTRO, 47(31), 2000, pp. NIL_21-NIL_21
Lifeline
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Lifeline, HEP-GASTRO, 46(30), 1999, pp. NIL_27-NIL_27
New frontiers in liver surgery. Two-stage liver surgery for the managementof advanced metastatic liver disease
Authors: Lygidakis, NJ Vlachos, L Raptis, S Rassidakis, G Balaskas, G Sgourakis, G Mourikis, D Kehagias, D Kittas, C
Citation: Nj. Lygidakis et al., New frontiers in liver surgery. Two-stage liver surgery for the managementof advanced metastatic liver disease, HEP-GASTRO, 46(28), 1999, pp. 2216-2228
Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma
Authors: Lygidakis, NJ Vlachos, L Raptis, S Sgourakis, G Mourikis, D Kehagias, D
Citation: Nj. Lygidakis et al., Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma, HEP-GASTRO, 46(28), 1999, pp. 2229-2239
Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regionalchemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial
Authors: Lygidakis, NJ Sgourakis, G Aphinives, P
Citation: Nj. Lygidakis et al., Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regionalchemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial, HEP-GASTRO, 46(27), 1999, pp. 2035-2038
Stop-flow thoracic perfusion for unresectable pulmonary carcinoma with or without inhalation IL-2 immunotherapy. A prospective randomized study
Authors: Lygidakis, NJ Safioleas, M Sgourakis, G Aphinives, P
Citation: Nj. Lygidakis et al., Stop-flow thoracic perfusion for unresectable pulmonary carcinoma with or without inhalation IL-2 immunotherapy. A prospective randomized study, HEP-GASTRO, 46(26), 1999, pp. 792-798
Transplenic and transtumoral in vivo immunostimulation: Effect on cellularimmunity parameters
Authors: Boura, P Kountouras, J Lygidakis, NJ Safioleas, M Aphinives, P
Citation: P. Boura et al., Transplenic and transtumoral in vivo immunostimulation: Effect on cellularimmunity parameters, HEP-GASTRO, 46(26), 1999, pp. 799-803
Metastatic melanoma: Transplenic immunostimulation - A new therapeutical alternative for an ever-challenging disease
Authors: Lygidakis, NJ Safioleas, M Sgourakis, G Spentzouris, N Dedemadi, G Sotiropoulou, P
Citation: Nj. Lygidakis et al., Metastatic melanoma: Transplenic immunostimulation - A new therapeutical alternative for an ever-challenging disease, HEP-GASTRO, 46(25), 1999, pp. 148-156
Hepato-gastroenterology - Current medical and surgical trends
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Hepato-gastroenterology - Current medical and surgical trends, HEP-GASTRO, 46, 1999, pp. NIL_17-NIL_17
Unresectable metastatic liver disease: New therapeutical alternatives
Authors: Lygidakis, NJ
Citation: Nj. Lygidakis, Unresectable metastatic liver disease: New therapeutical alternatives, HEP-GASTRO, 46, 1999, pp. 1297-1305
Risultati: 1-25 | 26-28